Intuitive Surgical Inc
$ 569.71
0.35%
03 Dec - close price
- Market Cap 204,227,658,000 USD
- Current Price $ 569.71
- High / Low $ 571.77 / 563.04
- Stock P/E 75.16
- Book Value 47.70
- EPS 7.58
- Next Earning Report 2026-01-22
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.10 %
- ROE 0.17 %
- 52 Week High 616.00
- 52 Week Low 425.00
About
Intuitive Surgical, Inc. is a premier American medical technology company that transforms surgery through its pioneering robotic-assisted surgical systems, notably the da Vinci Surgical System. The firm is dedicated to enhancing patient outcomes by developing minimally invasive surgical technologies, supported by an extensive portfolio of instruments, accessories, and comprehensive training programs for healthcare providers. With a strong emphasis on innovation, Intuitive Surgical is strategically positioned to capture growth opportunities in the rapidly evolving robotic surgery market, driving advancements in surgical precision and patient recovery rates.
Analyst Target Price
$592.96
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-10-16 | 2025-07-22 | 2025-04-22 | 2025-01-23 | 2024-10-17 | 2024-07-18 | 2024-04-18 | 2024-01-23 | 2023-10-19 | 2023-07-20 | 2023-04-18 | 2023-01-24 |
| Reported EPS | 2.4 | 2.19 | 1.81 | 2.21 | 1.84 | 1.78 | 1.5 | 1.6 | 1.46 | 1.42 | 1.23 | 1.23 |
| Estimated EPS | 1.99 | 1.92 | 1.73 | 1.79 | 1.64 | 1.54 | 1.41 | 1.48 | 1.41 | 1.33 | 1.2 | 1.25 |
| Surprise | 0.41 | 0.27 | 0.08 | 0.42 | 0.2 | 0.24 | 0.09 | 0.12 | 0.05 | 0.09 | 0.03 | -0.02 |
| Surprise Percentage | 20.603% | 14.0625% | 4.6243% | 23.4637% | 12.1951% | 15.5844% | 6.383% | 8.1081% | 3.5461% | 6.7669% | 2.5% | -1.6% |
Next Quarterly Earnings
| Dec 2025 | |
|---|---|
| Reported Date | 2026-01-22 |
| Fiscal Date Ending | 2025-12-31 |
| Estimated EPS | 1.83 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: ISRG
2025-12-04 16:33:10
Medtronic's Hugo surgical robot has received FDA clearance for urologic procedures in the U.S., positioning it as a significant challenger to Intuitive Surgical in the robotic surgery market. This authorization allows hospitals more choice in expanding their robotic programs, with plans to extend the robot's use to general surgery and gynecology in the future. The company anticipates this expansion will help revive growth in its medical/surgical portfolio and leverage its modular design and digital technologies as key differentiators.
2025-12-04 15:23:25
CONMED Corporation (CNMD) is positioned for growth due to the increasing adoption of its high-margin platforms like AirSeal and BioBrace, along with rising robotic procedure volumes and expanding Ambulatory Surgery Center penetration. Despite tariff headwinds and the launch of Intuitive Surgical's dV5 impacting AirSeal, improvements in supply chains and a strategic portfolio review are expected to drive top- and bottom-line growth. The company has a Zacks Rank #2 (Buy) and has consistently beaten earnings estimates.
2025-12-04 14:54:25
Medtronic's Hugo robotic-assisted surgery (RAS) system has received FDA clearance for urologic surgical procedures, a market segment representing approximately 230,000 surgeries annually in the U.S. This clearance opens a significant new market for Medtronic, with plans for expansion into other surgical specialties. Analysts anticipate U.S. sales to meaningfully contribute to the company's financials in fiscal years 2026 and 2027.
2025-12-04 11:42:00
This article summarizes a bullish thesis on Intuitive Surgical, Inc. (ISRG), highlighting its dominance in robotic-assisted surgery with the da Vinci system and a robust, high-margin business model. Despite competition and a rich valuation, the company's strong financial performance, recurring revenue, and long-term growth potential in minimally invasive surgery make it an attractive investment, particularly at lower entry points.
2025-12-04 08:59:44
Intuitive Surgical (ISRG) has seen its share price rally by about 25% over the past three months, prompting a re-evaluation of its valuation. While a fair value narrative suggests it's 3.9% undervalued at $592.96 due to innovation and growth prospects, other metrics show it trading at a significantly higher PE ratio than its industry and peers. Investors need to weigh the strong growth story against potential valuation risks and intense competition.
2025-12-04 01:49:00
A group of 6-12-year-old children from Los Gatos and San Jose had a unique opportunity to operate a high-end surgical robot at Intuitive Surgical, sparking their interest in science and technology. This hands-on STEAM experience, a result of a partnership between Good Samaritan Hospital and Intuitive Surgical, allowed kids to control tiny robotic instruments and see their movements on a 3D screen. The event aimed to make STEAM learning engaging and memorable, with both organizations hoping to offer similar experiences in the future.
